Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
Significant correlations seen for CD133 and Nanog between OPN in primary and recurrent tumor.
»
02/19/22
Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression
REST directly regulates CEMIP.
»
02/17/22
Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Risk reduction more pronounced in users younger than 60 years.
»
04/14/21
Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas.
Adverse prognostic impact of hPC observed only in luminal subtype.
»
03/02/21
Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population.
Non-US-born Hispanics had higher risk of GIM.
»
04/23/21
Prognostic Significance of Systemic Inflammation Indices by KRAS Status in Patients with Metastatic Colorectal Cancer.
KRAS genotype significantly influenced prognostic impacts of neutrophil/lymphocyte ratio.
»
02/23/22
Cell-free DNA technologies for the analysis of brain cancer.
Liquid biopsy advantageous when compared with both tissue sampling (less invasive) and imaging.
»
05/12/21
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
Incorporating urine liquid biopsy promising strategy.
»
12/15/21
Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry
Median OS of well-differentiated tumors 36 months.
»
03/01/22
Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy
Support inclusion of body composition assessment for prognostic stratification of rectal cancer patients.
»
02/25/22
< Prev
Next >